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A B S T R A C T
In line with experiments showing that implanted hydrogels are promising tools, we designed and injected, after a
C2 spinal cord hemisection, a thermoresponsive and thermoreversible physically cross-linked poly(N-iso-
propylacrylamide)-poly(ethylene glycol) copolymer in order to reduce functional deficits and provide a favor-
able environment to axotomized axons.
Nasal olfactory ecto-mesenchymal stem cells were cultured on the hydrogel in order to verify its bio-
compatibility. Then, inflammatory reaction (Interleukin-1β and 6, Tumor Necrosis Factor-α) was examined 15
days post-hydrogel injection. Functional recovery (postural and locomotor activities, muscle strength and tactile
sensitivity) was assessed once a week, during 12 weeks. Finally, at 12 weeks post-injection, spinal reflexivity and
ventilatory adjustments were measured, and the presence of glial cells and regenerated axons were determined
in the injured area.
Our results indicate that cells survived and proliferated on the hydrogel which, itself, did not induce an
enhanced inflammation. Furthermore, we observed significant motor and sensitive improvements in hydrogel-
injected animals. Hydrogel also induced H-reflex recovery close to control animals but no improved ventilatory
adjustment to electrically-evoked isometric contractions. Finally, regrowing axons were visualized within the
hydrogel with no glial cells colonization.
Our results emphasize the effectiveness of our copolymer and its high therapeutic potential to repair the
spinal cord after injury.
1. Introduction
In animal models of spinal cord injury (SCI), the implantation of
biomaterials seems to be a promising strategy allowing to reduce in-
flammatory reaction and glial scar formation, and to promote axonal
regeneration and functional recovery. These biomaterials can be nat-
ural (i.e., biopolymers of agarose, alginate, chitosan, collagen, fibrin
…), synthetic [poly(2-hydroxyethyl methacrylate) (pHEMA), poly
(lactic acid) (PLA), polyethylene glycol (PEG), poly(D,L-lactic acid-co-
glycolic acid) (PLGA) …. ] or hybrid (hyaluronic acid-PEG, chitosan-
methacrylamide, …), cytocompatible, non-immunogenic, chemically
stable, degradable and resorbable [1–9]. They have been used for de-
livering drug and cells, limiting the inflammatory reaction and the glial
scar development, filling the cystic cavities and/or providing structural
support for regenerating neurons after a SCI [10,11]. However, natural
and hybrid materials have some disadvantages like, among others, the
risk of disease transmission and the ability to provoke an immune re-
sponse [12].
Synthetic homopolymeric, co-polymeric and semi-/inter-pene-
trating polymer network hydrogels are attractive biomaterials to repair
the brain after a traumatic injury and bridge a cavity, after a SCI or a
peripheral nerve lesion [13–15]. They can be nontoxic and chemically
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inert. Furthermore, these polymers display other advantages. They are
composed of macromolecular networks of cross-linked hydrophilic
molecules or polymers, readily saturated with water, that mimic the
extracellular matrix (ECM) [9]. Being a 3D porous construction with
interconnected pores, they can act as a scaffold and allow cell migration
and nutriment diffusion as well as neovascularization of the implant
[7,16,17]. Contrary to natural hydrogels, they are more amenable to
modification (i.e., protein adsorption and cellular interaction depend of
the degree of hydrophilicity), easily reproduced and free of residual
growth factors and undefined and/or non-quantified constituents [18].
Thus, some of these synthetic hydrogels (co-polypeptide, poly-alkyli-
mide, hydroxy ethyl methacrylate [2-(methacryloyloxy)ethyl] tri-
methylammonium chloride (HEMA-MOETACl), poly(vinyl acetate)
(PVA)) have been proven to be biocompatible [19–23]. Others like PEG,
pHEMA, poly N-(2-hydroxypropyl)-methacrylamide (pHPMA) and poly
(2-hydroxyethyl methacrylate-co-methyl methacrylate) (PHEMA-
MMA), polyethylene glycol-poly-L-lysine (PEG-PLL) are able to reduce
the glial scar formation and/or to provide a cellular framework for
regenerating tissue in the injured spinal cord [14,24–40]. Among these
synthetic hydrogels, acrylamide and methacrylamide polymers, as ac-
rylate and methacrylate polymers, with similar mechanical properties
for the spinal cord [41], are suitable implantation materials that can i)
prevent the development of the glial scar and necrotic tissue and ii)
promote axonal regeneration and behavioral recovery [25,26,36,42].
In addition to these conventional hydrogels, “smart or intelligent”
hydrogels, responding for example to stimuli like pH, light radiation,
temperature, magnetic and electric field, ionic concentration, ultra-
sound were devised [43]. These stimuli-responsive hydrogels are of
great interest for complex SCI, displaying irregular and/or multi-shape
cavities (i.e., little void spaces and high tortuosities). Thus, in situ
forming hydrogels, be easily shaped or injected to fill the entire lesion
cavity offer a minimally invasive delivery compared to implanted hy-
drogels [44]. Indeed, hydrogel injected through a fine needle is less
invasive than physical implant and thereby facilitates surgery and re-
covery. In this context, self-assembling nanofibers, that spontaneously
aggregate from an aqueous solution into a stable gel in the presence of a
physiological salt solution or when the pH changes, were able to inhibit
glial scar formation and promote axon elongation after SCI [45]. Si-
milarly, synthetic self-assembling peptide amphiphile hydrogels, liquid
at ambient temperature and organized in nanofibers after injection in
the lesion cavity, reduce astrogliosis and cell death, while enhancing
axonal regeneration, when injected in injured spinal cord [19,46,47].
PLA-PEG-PLA triblock copolymer polymerized in situ using a photo-
initiator and light was used for delivery of NT-3 to the injured spinal
cord in rats [48].
Thermoresponsive hydrogels have the particularity to turn from
solution to gel when the temperature changes without any additional
external factor [49]. Hydrogels displaying a suitable low critical solu-
tion temperature (LCST) (i.e; a gelling behavior when the temperature
increases and reaches the body temperature) were intensively studied
but few were proposed for spinal cord repair. Among the main synthetic
hydrogels with thermosensitive sol-gel transition behavior and their
copolymers, poly(ethylene oxide)-b-poly(propylene oxide)-b-poly
(ethylene oxide) (PEO-PPO-PEO) triblock copolymer also, named
Pluronics®-F127 (poloxamer 407), was used for localized drug delivery
and cell encapsulation [50–56]. Oligo(ethylene glycol) methacrylate
(OEGMA) monomers have also been proposed for localized drug de-
livery [57]. Copolypeptide hydrogels containing poly(L-leucine), L, or
poly(γ-[2-(2-methoxyethoxy)ethyl]-L-glutamate-stat-L-leucine), (EP2/L)
and poly(γ-[2-(2-methoxyethoxy)ethyl]-rac-glutamate) were also con-
sidered for in vivo cell and molecule delivery [58]. Chen et al. reported
that injectable PLGA-PEG-PLGA triblock copolymer hydrogel, con-
taining or not dexamethasone, prevents epidural scar formation after
laminectomy [59]. More recently, it was reported that injection of poly
(organophosphazenes) into spinal cord contusion-provoked cavities
induce bridging effects with beneficial ECM remodeling and
regeneration of 5-HT axons, probably contributing to the recovery of
locomotor function, when combined to imidazole [60,61].
Poly(N-isopropylacrylamide) (PNIPAAm) and its copolymers are
thermoresponsive and thermoreversible hydrogels [62] that express
reversible swelling and shrinking behaviors when the temperature
fluctuates, without the use of toxic monomers or cross-linkers [63–65].
These semi-porous gels allow cell attachment, growth and spread in
certain conditions [66,67]. They were used for drug delivery, cell en-
capsulation and delivery and cell culture surfaces [68–74]. NIPAAm has
a LCST around 32 °C in pure water and, when copolymerized with a
more hydrophilic polymer, the LCST increases inside of the physiolo-
gical temperature range (i.e., 37 °C). Furthermore, when combined to
PEG, the mechanical and swelling properties of the polymer can be
tailored [63].
PEG is a biocompatible and non-toxic biodegradable synthetic ma-
terial that inhibits the inflammatory response following SCI, provides
neuroprotection (i.e., protects cell integrity and mitochondria, reduces
cell apoptosis, inhibits free radicals, prevents lipid peroxidation, …),
reduces microenvironment changes (glial scar and vacuoles formation,
cell aggregation, ….) and plays a role in nerve fiber regeneration [37].
However, it was suggested that PEG alone has several shortcomings and
the efficacy of PEG is not ideal. Indeed, PEG alone is an implantable
hydrogel that cannot fully fill the lesion cavity and mimic the 3D porous
structure of the spinal cord.
Finally, when NIPAAm is copolymerized with hydrophilic macro-
mers of methacrylated PEG, the syneresis of its hydrophobic chains is
minimized above the LCST, and its elastic property and porosity are
increased [63,75]. Furthermore, in vitro and at physiological tempera-
ture, its volume retention in Dulbecco's Modified Eagle's medium
(DMEM) with Nutrient Mixture F-12 with serum of PBS was around
100%, making it suitable for tissue engineering implants [76]. Finally,
by introducing a PEG block that changes the physicochemical proper-
ties of the copolymer, it becomes more biocompatible than Poloxamers
[75].
Thus, PNIPAAm-g-PEG combined to arginyl-glycyl-α-aspartyl-ser-
inyl (RGDS) peptide was used as cell culture material [77]. Further-
more, in order to repair a partial spinal cord injury, PNIPAAm-g-PEG
was combined to BDNF or NT-3 [76,78,79]. The authors demonstrated
that PNIPAAm-g-PEG hydrogel i) was biocompatible with mesenchymal
stem cells, ii) matched to the mechanical properties of the neuronal
tissue (i.e., compressive modulus between 3 and 5 kPa) and sustained a
drug release for up to 4 weeks. They showed that hydrogel was an ef-
fective vehicle for delivery of skin fibroblast transplants and was per-
missive to axonal growth. However, although the authors compared the
PNIPAAm-g-PEG hydrogel to commercially available collagen-based
matrices such as Gelfoam® and Vitrogen/PureCol®, they did not com-
pare their results to SCI animals without hydrogel injection. Further-
more, the PNIPAAm-g-PEG hydrogel used in these studies was chemi-
cally cross-linked (use of PEG-dimethacrylate), raising the problem of
impossible renal clearance and long-term tissue accumulation.
In the current study, before evaluating the in vivo functional per-
formance of a PNIPAAm-g-PEG hydrogel on a rodent model of cervical
spinal cord hemisection, the biocompatibility of the hydrogel was first
evaluated as a substrate for cultivated cells. Further, a cell-free hydrogel
was injected as viscous liquid into the lesion cavity, before formed a
semi-solid space-filling matrix. The host immune response to the hy-
drogel was evaluated, at Week 2 post-injection, by measuring the level
of tumor necrosis factor (TNF)-α and interleukin (IL)-1β and 6, with an
Elisa assay. Furthermore, sensory and motor recovery in the anterior
and posterior legs was weekly assessed, during 3 months, using 4 be-
havioral tests. Then, at Month 3, spinal reflexivity and physiological
adjustments to muscle fatigue were evaluated. Finally, the spinal cords
were collected for assessing of the presence of the hydrogel within the
lesion cavity and axonal growth. All injected animals were compared to
lesioned animals without gel insertion.
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2. Materials and methods
2.1. Animals
Experiments were performed on adult female Sprague Dawley rats,
weighing between 250-300 g (Élevage JANVIER®, Centre d’Élevage
Roger JANVIER, Le Genest Saint Isle, France), singly housed in smooth-
bottomed plastic cages in a colony room maintained on a 12-h light/
dark cycle and at 22 °C. Food (rat chow, Safe®, Augy, France) and water
were available ad libitum. The weight of the rats was daily controlled. In
order to accustom the animals to the laboratory environment, an ac-
climation period of 2 weeks was allowed before the initiation of the
experiment.
2.2. Ethical approval
Nasal olfactory stem cells were obtained from a healthy donor in-
formed about the study and the study design. He was also well informed
about the advantages and disadvantages of participation. The biopsies
were conducted in accordance with the Declaration of Helsinki and
were approved by the local ethical committee (Comité de Protection des
Personnes) of Marseille (IRB00005048). The donor provided its written
informed consent to participate in this study.
Animal anesthesia and surgical procedures were performed ac-
cording to the French law on animal care guidelines and were approved
by animal Care Committees of Aix-Marseille Université (AMU) and Centre
National de la Recherche Scientifique (CNRS). Individuals conducting the
research were listed in the authorized personnel section of the animal
research protocol or added to a previously approved protocol (License
n°A13.013.06). Furthermore, experiments were performed following
the recommendations provided in the Guide for Care and Use of
Laboratory Animals (U.S. Department of Health and Human Services,
National Institutes of Health) and in accordance with the European
Community's council directive of 24 November 1986 (86/609/EEC),
the ARRIVE Guidelines and the U.K Animal (Scientific Procedure) Act,.
1986. All these guidelines were carefully followed. No clinical sign of
screech, prostration, hyperactivity, anorexia and no paw-eating beha-
vior were observed through the study. If an animal had presented such
a sign, it would have been sacrificed.
2.3. PNIPAAM-g-PEG synthesis and characterization
Copolymer synthesis. Poly(N-isopropylacrylamide)-co-poly(ethylene
glycol)] methacrylate [p(NIPAAm-co-PEGMA)], also denoted as
PNIPAAm-g-PEG, was synthesized by radical copolymerization of N-
isopropylacrylamide (NIPAAm, Sigma Aldrich Merck, Saint Quentin
Fallavier, France) with poly(ethylene glycol) methacrylate (PEGMA).
PEGMA was first synthesized through reaction of polyethylene glycol
monomethylether (Me-PEG-OH, Sigma Aldrich Merck) with methacry-
loyl chloride (Sigma Aldrich Merck). In brief, 10 g (5mmol) of Me-PEG-
OH (Mn=2000 gmol-1) was allowed to react with 5.2 g (49.7 mmol) of
methacyloyl chloride (added dropwise) in 100ml of dichloromethane
(DCM), in presence of 7ml (50.2mmol) of triethylamine (TEA, Acros
Organics, Illkirch, France). After 20 h under stirring at room tempera-
ture, DCM was removed under reduced pressure and the crude product
was diluted with tetrahydrofuran (THF, VWR International S.A.S,
Fontenay-sous-Bois, France). After filtration of the TEA salts, the crude
solution was precipitated in 90% diethyl ether and 10% ethanol mix-
ture, and dried under vacuum; 1H NMR (CDCl3): δ 1.95 (s, 3H, -C-CH3),
3.38 (s, 3H, O-CH3), 3.64 (s, 180H, -CH2-), 4.29 (t, 2H, -CH2-OC(O)-),
5.57 and 6.13 (s, 1H+1H, -CH2=C).
For copolymerization, NIPAAm (3.68 g), PEGMA (0.263 g) and
azobisisobutyronitrile (AIBN, Sigma Aldrich Merck) initiator (0.10 g)
were dissolved in methanol (30ml) in a two-neck round-bottom flask
fitted with a septum and a reflux condenser, and the solution degassed
for 30min by argon bubbling. The flask was then immersed in an oil
bath at 68 °C, and the polymerization allowed to run for 20 h. After
reconcentration of the mixture by methanol evaporation under reduced
pressure, the copolymer was precipitated twice in diethyl ether and
dried under vacuum.
Copolymer characterization. Polymers were characterized by 1H NMR
in chloroform-d (CDCl3) or in deuterated dimethyl sulfoxide (DMSO‑d6)
with Bruker Advance 400MHz spectrometer, and by size exclusion
chromatography (SEC) using a Varian PL-GPC 120 apparatus, com-
posed of a robotic autosampler (PL-AS-MT, Agilent Technologies, Les
Ulis, France), a pump (Agilent 1100 series, Agilent Technologies), a
degasser, an injection valve, a column oven and a refractive index (RI)
detector. The following columns were used: one pre-column and two PL
Resipore columns (300mmÅ∼ 7.8mm). The injection loop, the col-
umns and the RI detector were in the same oven thermostated at 70 °C.
The eluent was a solution of 0.1M LiBr in N,N-dimethylformamide
(DMF) filtered through a 0.45 μm nylon membrane and the flow rate
was fixed at 0.7mlmin-1. The samples were prepared in a mixture of
eluent and toluene (0.25 vol%) as the flowmarker, filtered through a
0.2 μm nylon filter (Interchim) and placed in an autosampler preheated
at 50 °C. The sample concentration was 0.25wt%. Calibration curve
were established with poly(methyl methacrylate) (PMMA, Agilent
Technologies). Lower critical solution temperature (LCST) of the co-
polymer was determined by dynamic light scattering analysis 0.6 wt%
copolymer solution in PBS (pH 7.4). The hydrodynamic diameter and
the count rate were measured using a Zetasizer Nano ZS apparatus
(Malvern Panalytical SARL, Orsay, France). After equilibration at 25 °C,
the temperature was incremented in steps of 1 °C until 40 °C. For each
step, an equilibration period was fixed at 2min.
Then, the copolymer was dissolved at 13.7 wt% in PBS and heated
to 37 °C, at which the hydrogel quickly formed. Rheological properties
of the hydrogel at 37 °C were analyzed with a rheometer (MCR 302,
Anton Paar S.A.S., Les Ulis, France) equipped with a 25mm diameter
aluminum parallel disks. A volume of 0.6 ml of copolymer solution at
13.7 wt% in PBS was charged on the inferior disk at 20 °C. The solution
was then heated to 37 °C to form a hydrogel with a gap width of
0.9 mm. The complex shear modulus (G=G’+iG”) was then measured
as a function of frequency by dynamically shearing the hydrogel at a
fixed strain of 1% over the frequency range 0.1–100 rad s-1 at 37 °C. All
measurements were performed in a dry air atmosphere.
2.4. Survival and proliferation of nasal olfactory ecto-mesenchymal stem
cells
Before evaluating the in vivo functional performance of the
PNIPAAm-g-PEG hydrogel, the biocompatibility of the hydrogel was
assessed in vitro on cell cultures. Nasal biopsies were immediately
placed in growth medium containing DMEM/Ham F12 supplemented
with 10% foetal bovine serum (FBS) and 100 units/ml of penicillin and
100 μg/ml of streptomycin (Invitrogen®, Thermo Fisher Scientific, Life
Technologies SAS, Courtaboeuf, France). Olfactory ecto-mesenchymal
stem cells were purified from the lamina propria and belong to the sub-
family of ecto-mesenchymal stem cells as described before [80]. Briefly,
the biopsies were incubated in a Petri dish filled with 1ml of dispase II
solution (2.4 IU/ml), for 1 h at 37 °C. Next, the olfactory epithelium was
removed from the underlying lamina propria using a micro spatula.
Once purified, the lamina propria was cut into small pieces with two 25
gauge needles and transferred into a 15ml tube filled with 1ml of
collagenase IA. After a 10min incubation at 37 °C, the tissue was me-
chanically dissociated and the enzymatic activity was stopped by
adding 9ml of Ca-free and Mg-free PBS. After centrifugation at 200g for
5min, the cell pellet was resuspended in DMEM/Ham F12 culture
medium, supplemented with penicillin/streptomycin and 10% fetal calf
serum, and plated on plastic culture dishes. The culture medium was
renewed every 2–3 days.
In order to quantify survival and proliferation of olfactory me-
senchymal stem cells when loaded in the PNIPAAm-g-PEG, we
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performed a gel spot assay. Hydrogel was diluted into sterile PBS in
order to make a 13.7% solution. After passaging with trypsin, cultivated
olfactory mesenchymal stem cells were collected, centrifuged and
counted. In each well, 40,000 stem cells were loaded in 50 μl of the gel,
at room temperature, and the plates were immediately transferred into
a 37 °C incubator to allow each spot to solidify. The Petri dishes were
then gently filled with serum-containing medium, renewed every 2/3
days. On Day 3, 6, 14 and 21, cells were collected and stained with
Trypan blue before being quantified, using a Malassez counting
chamber.
2.5. Protocol design and experimental groups
Thirty five animals were randomly assigned to the 3 following
groups: 1) SHAM (n = 5), surgery was performed but without spinal
cord injury, 2) Lesion group (n = 15), a C2 cervical hemisection was
performed, 3) Lesion + PNIPAAM group (n = 15), a C2 cervical
hemisection was followed by an immediate injection of PNIPAAm-g-
PEG hydrogel in the lesion cavity.
Five animals of the Lesion and Lesion + PNIPAAM groups were
sacrificed two weeks after the SCI to evaluate the endogenous in-
flammation at the lesion site. For other animals (n = 25), sensory and
motor recovery in the anterior and posterior legs were followed during
3 months after the injury and injection of the hydrogel into the lesion
cavity by using 4 behavioral tests. Then, at Month 3, spinal reflexivity
and physiological adjustment to muscle fatigue were evaluated and the
spinal cords were collected for assessing of the presence of the hydrogel
within the lesion cavity and axonal growth.
2.6. Surgery
Animals were anesthetized with a 3% isoflurane (Isoflurin®, Axience
Santé Animale SAS, Pantin, France) in oxygen (1 l min-1) and placed in a
stereotaxic frame. Under aseptic conditions, surgery was performed as
previously described [81,82]. In the SHAM group, following a midline
dorsal incision, the superficial muscles were retracted to expose the
cervical vertebrae. Then, a laminectomy was performed without af-
fecting the integrity of the spinal cord. In the two other groups, using
microscissors the dura was incised and the left side of the C2 spinal cord
was hemisected from the midline to the lateral part. This high cervical
spinal cord hemisection interrupts descending tracts as well as pro-
priospinal pathways to thoracic and lumbosacral segments [83,84]. It
induces a central deafferentation of the phrenic motoneurones and a
functional quiescence of the ipsilateral hemidiaphragm as well as dys-
function of muscles of ipsilateral forelimb and muscles of both hin-
dlimbs [85].
Using a micropipette, 2× 10 μl of sterile PNIPAAm-g-PEG were
injected into the lesion cavity of animals from the Lesion + PNIPAAM
group. After waiting a few minutes, gelation of the hydrogel in situ was
observed. In all operated animals, muscles and skin were sutured
(Vicryl® 3-0, Ethicon, Issy Les Moulineaux, France) in anatomical layers
and the wound was disinfected with an antiseptic (Betadine®, 5%, Meda
Pharma, Paris, France) and saline (2ml of 0.9%) was injected sub-
cutaneously. Furthermore, all animals were kept in a heated room
overnight and treated during one week post-surgery with buprenorphin
(0.03mg/kg, Buprécare®, Axience Santé Animale SAS). Animal hydra-
tion and gastrointestinal function were monitored twice a day and
bladders were manually expressed when necessary. Antibiotic
(Amoxicillin trihydrate, 45mg/ml, Synulox®, Zoetis SA, Malakoff,
France) were preventively given for two weeks following surgery to
prevent any infection.
2.7. Endogenous inflammation
Two weeks post-lesion, to evaluate the endogenous inflammation
and the effect of hydrogel injection at the lesion site, animals from
Lesion and Lesion + PNIPAAM groups were sacrificed with a lethal
dose of anesthetic (Pentobarbital sodium, 390 mg/kg, i.p., Euthasol®
Vet., Dechra Veterinary Products S.A.S., Montigny-le-Bretonneux,
France). A segment of spinal cord extending 5 mm rostral and caudal to
the injury site was quickly removed and frozen immediately in iso-
pentane and stored at -80 °C until further processing. The spinal cord
tissues were homogenized separately in 1 ml of Phosphate Buffer
Sodium (PBS) for 30 s by a handheld homogenizer (Ika Ultra Turrax®
disperser, Fisher Scientific SAS, Illkirch, France), which has connecting
plastic pestle tips that homogenize the tissue through vibrating mo-
tions. Then, the resulting mixtures were centrifuged (centrifuge Sigma
2-16 PK Centrifuge Fisher Scientific SAS, Illkirch, France) for 12 min
(2000×g, 4 °C) and a fraction (50 μl) of the supernatant of the homo-
genate containing soluble proteins was used to evaluate inflammation.
The concentrations of IL-1β, IL-6 and TNF-α, in spinal cord tissue
homogenates were measured using enzyme-linked immunosorbent
assay (ELISA) kits containing specific antibodies (RAB0272, RAB0311
and RAB0480, Sigma Aldrich®, Saint-Quentin Fallavier, France), ac-
cording to the manufacturers’ instructions. Each sample was analyzed
twice. Absorbance was determined using a microplate reader
(Multiskan® Microplate Photometer, Thermo Fisher Scientific, Life
Technologies SAS, Courtaboeuf, France) at a wavelength of 450 nm.
The concentration of inflammatory mediators in each sample was ob-
tained by comparison with samples containing known amounts of in-
flammatory mediators. Then, a curve linking the concentration to the
measured absorbance was computed. Concentrations were based on the
amount of tissue weighed before homogenization and expressed in pg
per g of spinal cord.
2.8. Behavioral tests
Before surgery, in order to decrease inter-individual differences, all
animals were familiarized with the 4 behavioral tests, 3 days per week
during two weeks. This acclimation period allows animals to reach
optimal performances. The day before surgery, reference values (PRE-)
of each test were recorded. Then, during 12 weeks (W1 to W12), the
tests were performed, once a week, by the same experimenter in order
to obtain more reproducible and reliable data.
BBB-derived test (Martinez's Scale). Deficits and recovery of sensor-
imotor functions were assessed using a tool derived from the BBB test
[86]. Briefly, animals were place in an open-field environment made of
a circular Plexiglas® enclosure arena (95-cm diameter, 40-cm wall
height) with an anti-skid floor. The scale comprises eight categories that
allow for separate evaluation of the forelimbs and hindlimbs: articular
movements of the affected limbs, weight support, digit position, paw
placement, orientation and movement during stepping, limbs co-
ordination and tail position. A total maximum score of 20 points in-
dicates normal locomotion or full functional recovery. In order to assess
separately forelimb and hindlimb functions, animal movements were
video-recorded during sessions of 4min duration (MV 830i; Canon®,
Courbevoie, France) and analysis was carried out later on.
Ladder climbing test. From 1 week after surgery, cortical control of
fine sensorimotor coordination was tested during a climbing task.
Climbing a ladder is an easily acquired spontaneous response, requiring
neither compulsion nor reward. As previously described [82,87,88],
this test was used to evaluate the sensorimotor capacities to correctly
grip the rung while rats climbed up an inclined ladder
(10 cm×150 cm; rod diameter: 0.4 cm; distance inter-rods: 2 cm) at a
45° angle. The climbing test was repeated one time a week for twelve
successive weeks. Unoperated animals climb readily, with all four paws
locating and grasping the rods without fault. In all operated animals,
the forepaw on the operated side showed varying degrees of difficulty
in locating the ladder rods. As a result, a climbing score ranging from 0
(without success, i.e., 0 grip with the forepaw ipsilateral to the lesion)
to 40 (animal climbed 40 rods of the ladder without faults, i.e., 20 grips
with the forepaw ipsilateral to the lesion) was calculated and
M. Bonnet, et al. Materials Science & Engineering C 107 (2020) 110354
4
normalized to the maximal score. The mean ratio obtained at each
session was expressed as percentage of the mean ratio obtained at week
0 (PRE-). All the details regarding how to calculate the score are given
in a previous article [82].
Grip strength test. As previously described the force exerted by both
forepaws/forelimbs was measured using a grip force tester [Grip
Strength Tester (GST) bio-GT3, Bioseb apparatus, Vitrolles, France]
[82,89]. Animals were tested once a week by the same experimenter in
order to obtain more reproducible and reliable data. Four maximal
forces (in grams) were averaged over 3-5 trials. Results were normal-
ized by the weight (in grams) of the animal (force/weight ratio) and
expressed as percentage of the ratio obtained at week 0 (PRE-).
Tape removal test. In order to test the sensory function, rats were
placed individually in a transparent rectangular cage (30 cm×20 cm)
and a piece of adhesive tape (Scotch®, 3 M, Pontoise, France) of 25mm2
(5× 5mm) was affixed to the palm of the forelimb [90,91]. This ad-
hesive tape causes discomfort for the animal that will remove it quickly
with his mouth. This behavior implies correct paw and mouth sensi-
tivity (time-to-contact) and correct dexterity (time-to-remove). The
time from the tape was affixed until it was detected by the animal was
measured in three individual trials to calculate the mean sensing time.
The left (ipsilateral to the lesion) and right forelimbs were separately
tested and the asymmetric score was calculated using the following
formula: TL/(TL + TR), where TL and TR were the mean sensing time
measured in the left and in the right forelimb, respectively. The
asymmetric score ranges from 0 (full sensory deficit on the right fore-
limb compared to the left forelimb) to 1 (full sensory deficit on the left
forelimb compared to the right forelimb). A score of 0.5 indicates
symmetry of tactile sensitivity between the two forelimbs. If an animal
did not detect the tape, the trial was stopped after 180 s and this value
was taken as the time recorded.
2.9. Electrophysiological recordings
Twelve weeks post-injury, animals were anesthetized by in-
tramuscular injection of ketamine (62.5 mg/kg-1, 100mgm-1, Ketamine
1000®, Virbac®, Carros, France) and xylazine (3.125mg kg-1, 20mgml-
1, Xilasyn®2, Virbac®), and prepared for electrophysiological recordings
as previously described [81,82]. Briefly, the ulnar nerve from the left
forelimb was dissected free from surrounding tissues for stimulation.
Then, Flexor Digitorummuscle from the left forelimb and Tibialis anterior
muscle from the left hindlimb were exposed for electromyographic
(EMG) recording and stimulation, respectively.
M- and H-waves. As previously described [25,81,82,92–98], the H-
reflex rate sensitivity (i.e., the decrease in reflex magnitude relative to
repetition rate) was analyzed. In order to calculate the H-reflex rate
depression, the Hmax/Mmax ratio obtained at the stimulation frequency
of 1, 5 and 10 Hz was expressed as a percent of the Hmax/Mmax ratio
obtained at the baseline frequency of 0.3 Hz.
Physiological reflexes. Ventilatory adjustments were measured after
activation of metabosensitive afferent fibers by Tibialis anterior muscle
repetitive stimulation and under regional circulatory occlusion
[25,81,82,92,99]. Thus, changes in ventilatory frequency after elec-
trically-induced muscle fatigue (EIF) was expressed in percent [Δcycle/
min (%)] of the mean cycles recorded 2min before muscle stimulation.
2.10. Euthanasia and histological analysis
According to ethical recommendations, at the end of each series of
electrophysiological recordings, the animal was sacrificed with an
overdose of anesthetic (Pentobarbital sodium, 390mg/kg, i.p.,
Euthasol® Vet.) and the C1-C5 spinal segment was removed, rinsed in
cold phosphate buffer saline (PBS) 0.1M and frozen on dry ice. All
samples were then stored at -80 °C. Then, 50-μm thick horizontal sec-
tions were performed using a cryostat (CM1950, Leica Biosystemes S.A.,
Nanterre, France). Slices were collected on SuperFrost Ultra Plus™
(Thermo Fisher Scientific) glass slide and sampled every five sections.
After a 15min dip in a solution containing 4% of paraformaldehyde
followed by 4 rinsing in cold PBS, the spinal sections were used to
perform double indirect immunofluorescence detection against Glial
Fibrillary Acidic Protein (GFAP, Agilent Technologies, Inc., Les Ulis,
France) and 70 kDa Neuro-Filament (NF, Agilent Technologies, Inc.).
Before incubation of antibodies, sections were subjected to several pre-
treatments to improve antibody-binding specificity and to reduce
nonspecific signals. They were incubated in 0.1M lysine (Sigma Aldrich
Merck) and then permeabilized with 0.3% TritonX100 (Sigma Aldrich
Merck). Nonspecific sites were blocked with 2% bovine serum albumin
(Sigma Aldrich Merck). Incubations were carried out for 48 h at 4 °C
with the primary antibodies diluted in PBS including 2% bovine serum
albumin and 0.3% TritonX100 at the following dilutions: rabbit anti-
body against GFAP (1/500, Agilent Technologies, Inc.) and mouse an-
tibody against NF (1/1000, Agilent Technologies, Inc.). After rinses
with PBS, sections were incubated for 2 h at room temperature with a
goat anti-rabbit Ig G and a goat anti-mouse Ig G secondary antibodies
(1/200) conjugated a red- and green-fluorescent dyes (Alexa Fluor® 594
and 488, Invitrogen®, Molecular Probes® Product Brands), respectively.
Sections were observed by epifluorescence optical microscopy using an
Eclipse E600 microscope (Nikon®, Champigny-sur-Marne, France).
Measurements and microphotographs were performed with an ana-
lyzing software (Lucia®, Lim Laboratory Imaging s.r.o., Praha, Czech
Republic).
2.11. Statistical analysis
Analysis of ELISA data was performed with a t-test. Results obtained
from behavioral tests and electrophysiological recordings were com-
pared between all experimental groups. Data processing was performed
using a software program (SigmaStat®, San Jose, CA, USA). Normal
data distribution was verified and a two-way ANOVA (group factor x
time factor or stimulation frequency factor) for repeated measures was
used to compare groups with each other and over time for behavioral
scores and over stimulation frequency for Hmax/Mmax. Then, statistics
were completed with a multiple-comparison post-hoc test (Student-
Newman-Keuls method). Wilcoxon and Mann-Whitney tests were used
to determine the ventilatory increase after the stimulus was applied and
for histological analysis, respectively. Data were expressed as
mean ± SEM. Results were considered significant if the p-value fell
below 0.05.
3. Results
3.1. PNIPAAM-g-PEG synthesis
The copolymer composition (94/6wt% in NIPAAm/PEG, de-
termined from 1H NMR integration, Fig. 1A) and molecular weight
(83000 gmol-1, Đ= 1.9, from SEC) were adjusted to ensure both sui-
table LCST (33 °C, sufficiently below 37 °C, Fig. 1B) and chain en-
tanglement. At 13.7 wt% in physiological solution (PBS, pH 7.4), hy-
drogel formation occurred instantaneously at 37 °C (Fig. 1C). The
storage modulus (G′) and loss modulus (G″) of the copolymer hydrogel
were investigated at 37 °C by varying angular frequency from 0.1 to
100 rad s-1 to assess the rheological behavior of the hydrogel in condi-
tions close to in vivo. Values were in the range 25–50 kPa and 17-
20 kPa, respectively (Fig. 1D).
3.2. Animals
All operated rats survived until the electrophysiological phase or
during the two weeks (rats used to evaluate endogenous inflammation)
following the surgery. Except the 10 rats sacrificed 2 weeks after the
SCI, all animals underwent all weekly behavioral tests. Their weight did
not drop throughout the experiment. The injury resulted in pronounced
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motor deficits in the ipsilateral limbs and in bilateral sensory deficits.
Furthermore, the ipsilateral hemidiaphragm became functionally
quiescent. The high cervical spinal cord hemisection interrupted motor
descending pathways as well as propriospinal pathways to thoracic and
lumbosacral segments. It also interrupted sensory ascending pathways.
3.3. Survival and proliferation of olfactory ecto-mesenchymal stem cells
Measurement of the number of cells from the day (D0) of seeding to
the fourteenth day (D14) revealed that from the sixth (D6) day the
number of cells was significantly higher (D6, p < 0.01; D14,
p < 0.001; D21, p < 0.001) than that at D0. Within the 21 days on
culture the number of cell increased exponentially and cells were 5
times more numerous at D21 (267800 ± 12635 cells) when compared
to D0 (40000 cells) (Fig. 2).
3.4. Endogenous inflammation
Measurement of IL-1β, IL-6 and TNF-α levels at the lesion site did
not reveal difference between Lesion and Lesion + PNIPAAM groups
indicating that the hydrogel did not produce additional inflammation
within the 2 weeks following injection (Fig. 3).
3.5. Behavioral tests
No difference was observed from PRE-measurements until week-12
(W12) in the SHAM group for the 4 behavioral tests.
BBB-derived test (Martinez's Scale). Analysis of the BBB scores during
the 12 weeks following the surgery revealed that the SHAM group had
relatively stables values closed to the maximal PRE-values. However, in
the two lesioned groups, the scores dropped significantly (p < 0.001)
at Week 1 (W1) post-surgery and, although remaining lower
(p < 0.001) than the SHAM group, recovered from the 2nd to the 12th
week with higher (p < 0.001) scores for Lesion + PNIPAAM group
than Lesion group (Fig. 4).
Ladder climbing test. Analysis of the climbing scores during the 12
weeks following the surgery revealed that the SHAM group had rela-
tively stables values closed to the maximal PRE-values. However, in the
two lesioned groups, the scores dropped significantly (p < 0.001) at
W1 post-surgery. Throughout the 3 months post-surgery, the scores in
the two lesioned groups were lower than in the SHAM group.
Furthermore, in the Lesion + PNIPAAM group a recovery was observed
from the 3rd to the 12th week with higher (W3, p < 0.05; W4 to W12,
p < 0.001) scores for the Lesion + PNIPAAM group compared to the
Lesion group. Scores of the Lesion group remained relatively stable
from WI to W12 (Fig. 5).
Grip strength test. Analysis of the force developed in each forelimb
indicated that the force dropped significantly (p < 0.001) at W1 after
the spinal lesion in the ipsilateral side (left limb) in the Lesion and
Lesion + PNIPAAM groups compared to the force developed by the
forelimbs of the SHAM group or controlateral forelimb of the respective
group. Furthermore, in the lesioned groups, the force of the ipsilateral
Fig. 1. Hydrogel preparation and char-
acterization. A. 1H NMR of the
PNIPAAm-g-PEG copolymer in
DMSO‑d6 (met.=methanol traces; -C-
CH3 and -CH2-OC(O)- protons from the
original PEGMA are overlapped); B.
LCST of the copolymer determined by
DLS (PBS, pH 7.4); C. Hydrogel forma-
tion at 37 °C (13.7 wt% in PBS, pH 7.4);
D. Storage modulus (G′) and loss mod-
ulus (G″) of the copolymer hydrogel
(13.7 wt% in PBS, pH 7.4) at 37 °C.
Fig. 2. Cell survival and proliferation. Measurement of the number of cells, from
the day of seeding (D0) to D21, reveals an exponential increase. Significant
differences at D0, D3, D6 and D14 are indicated by *, +, ψ and Δ, respectively.
(1 symbol, p < 0.05; 2 symbols, p < 0.01 and 3 symbols, p < 0.001).
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forelimb to the lesion remained lower during the 12 weeks of experi-
ment. However, in the Lesion + PNIPAAM group, a recovery was ob-
served from the 5th to the 12th week (W5 and W6, p < 0.01; W7 to
W12, p < 0.001); the force developed in the left forelimb was sig-
nificantly higher than that developed in the left forelimb of the Lesion
group (Fig. 6).
Tape removal test. Analysis of the asymmetric score indicated that
the mean sensing time measured in the left forelimb (ipsilateral to the
lesion) increased drastically after the C2 hemisection. However, while
asymmetric scores were measured in the Lesion and
Lesion + PNIPAAM groups until the end (W12) of the experiment, from
the W3 to the W12, the score became significantly lower in the
Lesion + PNIPAAM group than in the SHAM group (Fig. 7).
3.6. Electrophysiological recordings
M- and H-waves. In the left (ipsilateral) foreleg, the value of the
Hmax/Mmax ratios measured at the baseline stimulation (0.3 Hz) were
0.38 ± 0.06, 0.46 ± 0.11 and 0.37 ± 0.06 for SHAM, Lesion and
Lesion + PNIPAAM groups, respectively. The ratio of the Lesion group
was significantly higher (p < 0.01) than ratios of other groups.
Furthermore, frequency-dependent values of H-reflex analysis (Fig. 8)
indicated that when the frequency of stimulation was increased to 1 Hz,
the Hmax/Mmax ratio slightly decreased for the SHAM (91.42 ± 3.15%)
and Lesion + PNIPAAM (94.49 ± 3.02%) groups and increased for the
Lesion group (105.04 ± 2.87%). These changes were not significantly
different than the ratio measured at 0.3 Hz. Moreover, no statistical
difference was found between groups. At 5 Hz stimulation, a significant
(p < 0.001) decrease was observed in the SHAM group
(78.35 ± 3.56%) compared to the values obtained at 0.3 Hz and no
significant change was noted in the two other groups (Lesion:
108.29 ± 6.81% and Lesion + PNIPAAM: 89.87 ± 4.90%). How-
ever, comparison between groups indicated a significant difference
between the Lesion group and the other two groups (SHAM: p < 0.001
and Lesion + PNIPAAM: p < 0.01). At 10 Hz stimulation, ratios of
SHAM (61.04 ± 6.89%) and Lesion + PNIPAAM (76.90 ± 7.38%)
groups decreased significantly (p < 0.001) compared to the values
obtained at 0.3 Hz. Comparisons between groups showed significant
difference between the lesion group and the two other groups (SHAM:
p < 0.001 and Lesion + PNIPAAM: p < 0.05). Finally, a significant
difference (p < 0.05) was also noted between the SHAM and the Le-
sion + PNIPAAM groups. These last two groups had the same response
profile, namely a decrease of the Hmax/Mmax ratio with the increase of
the stimulation frequency and from 1Hz. This result can be correlated
with functional outcome in animals receiving the hydrogel.
Physiological reflexes. Ventilatory frequency measured after left (ip-
silateral) peroneal nerve stimulation was only significantly (p < 0.01)
increased in the SHAM group (+6.23 ± 1.12%). Compared to the
resting data, in the Lesion group a slight decrease (-5.20 ± 1.64%) was
observed. In the Lesion + PNIPAAM group the slight increase
(+0.5 ± 0.7%) was not significant. Comparison between groups in-
dicated a significant difference (p < 0.01) between the SHAM group
and the two other groups.
3.7. Histological analysis
Spinal damages are known to lead to the development of cavities
surrounded by a glial scar called cysts. In animal receiving the hy-
drogel, histological analysis showed that all these cysts were filled up
by the polymer. Beyond the stability of this substance, it was noted that
no cell invaded the hydrogel. Glial processes only weakly colonized the
hydrogel (Figue 9A). Some rare GFAP-immunoreactive (GFAP-Ir) pro-
cesses have been observed on the periphery without ever entering more
than 15 μm within the hydrogel. Regarding the neuronal processes, the
NF-immunoreactive (NF-Ir) was still observable in the spare funiculi
(Fig. 9B) but the density of NF-Ir fibers was strongly decreased in the
glial scar (Fig. 9C). Only a few of these processes are detectable in this
region. Conversely, numerous NF-Ir processes were visible within the
hydrogel. These fibers were highly labeled and mainly exhibited a
rostro-caudal orientation, as in the spare tissues.
4. Discussion
The aim of our research was to evaluate the therapeutic potential of
Fig. 3. Inflammatory reaction at the lesion site. Comparison of IL-1β, IL-6 and TNF-α levels at the site of injury in the Lesion and Lesion + PNIPAAM groups, two week
post-injury, does not reveal any additional inflammation when the hydrogel is added.
Fig. 4. BBB-derived locomotor rating
scale. Significant difference in the BBB-
derived scores is indicated by a *
(Lesion group, PRE-vs. post-surgery), +
(Lesion + PNIPAAM group, PRE-vs.
post-surgery), δ (SHAM group vs.
Lesion and Lesion + PNIPAAM groups)
and Ω (Lesion group vs.
Lesion + PNIPAAM group). (3 sym-
bols, p < 0.001).
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the poly(N-isopropylacrylamide)-poly(ethylene glycol) copolymer
(PNIPAAm-g-PEG) after injection in a rat hemisectioned spinal cord. We
hypothesized that a compatible synthetic hydrogel that fills the lesion
cavity could limit the development of glial scar, allow axonal re-
generation and accelerate post-traumatic functional recovery. For the
first time, the current study demonstrates that human cells survive and
proliferate when cultivated within the hydrogel. In vivo, measurement
of cytokines (IL-1, IL-6 and TNF-α) indicates that hydrogel did not in-
duce additional inflammatory reaction within the first 2 weeks post-
injection in the lesion cavity. Motor and sensory recovery is enhanced
in hydrogel-implanted animals and, at twelve weeks post-injury, ana-
lysis of the H-reflex reveals the restoration of the post-activation de-
pression in grafted rats. Finally, neurofilament-positive axons invade
the gel while astrocytes remain at the periphery.
4.1. PNIPAAm-g-PEG display mechanical properties suitable for spinal cord
repair
Due to its suitable LSCT between room and physiological tempera-
ture (∼32 °C), PNIPAAm is attractive for designing injectable hydro-
gels. However, its pronounced hydrophobicity above LCST requires
introduction of hydrophilic moieties to ensure water retention and
prevent gel shrinkage [100]. Our approach relied on a PNIPAAm co-
polymer grafted with PEG segments, yielding physical hydrogel upon
PNIPAAm collapsing above transition temperature. We opted for phy-
sically cross-linked hydrogels instead of chemically based ones (e.g.
using PEG diacrylates) [79] for enabling copolymer to be potentially
excreted through renal clearance, even if the molecular weight of our
copolymer (about 80 kgmol-1) was slightly higher than commonly
Fig. 5. Ladder climbing test. Significant
difference in the climbing scores is in-
dicated by a * (Lesion group, PRE-vs.
post-surgery), + (Lesion + PNIPAAM
group, PRE-vs. post-surgery), δ (SHAM
group vs. Lesion and
Lesion + PNIPAAM groups) and Ω
(Lesion group vs. Lesion + PNIPAAM
group). (1 symbol, p < 0.05 and 3
symbols, p < 0.001).
Fig. 6. Grip strength test. Significant
difference in the maximal force devel-
oped in the forelimbs is indicated by a *
(Lesion group, left forelimb, PRE-vs.
post-surgery), + (Lesion + PNIPAAM
group, left forelimb, PRE-vs. post-sur-
gery), λ (Lesion group, left forelimb vs.
SHAM group, left and right forelimbs
and Lesion and Lesion + PNIPAAM
groups, right forelimb), ψ
(Lesion + PNIPAAM group, left fore-
limb vs. SHAM group, left and right
forelimbs and Lesion and
Lesion + PNIPAAM groups, right fore-
limb) and Ω (Lesion group, left forlimb
vs. Lesion + PNIPAAM group, left
forelimb). (2 symbols, p < 0.01 and 3
symbols, p < 0.001).
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reported renal cutoff (≈70 kDA) to ensure sufficient mechanical
properties [101]. The copolymer was obtained by radical copolymer-
ization of NIPAAm and PEGMA and values of the storage modulus (G′)
and loss modulus (G″) typically matched with those of spinal cord
[102]. Thus, because of its mechanical properties, our hydrogel was a
very good candidate to replace the spinal cord tissue lost during the
mechanical injury.
4.2. PNIPAAm-g-PEG supports survival and proliferation of human stem
cells in vitro
If NIPAAm monomer was considered as a toxic agent for living cells,
there are conflicting opinions concerning the toxicity of the
polymerized form of NIPAAM [103,104], known to be associated to
concentration, temperature and incubation. However, in order to
counteract its potential toxicity, PNIPAAm was combined with PEG.
Thus, it was shown that PNIPAAm-g-PEG may support the survival of
SH-SY5Y human neuroblastoma cells [105].
In this context, the first step in this process was to check the toxicity
of the PNIPAAm-g-PEG hydrogel by seeding human olfactory ecto-me-
senchymal stem cells (hOE-MSCs) in the hydrogel. Our results indicate
that, within 21 days, the cells proliferated, reaching a five fold increase.
This result confirms previous studies showing the potential of
PNIPAAm-g-PEG 3-dimensional hydrogel to support the survival and
development of human stem cells. Indeed, Comolli et al. [76] showed
that PNIPAAm-g-PEG scaffolds are capable of supporting human bone
Fig. 7. Tape removal test. Significant
difference in the asymmetric scores is
indicated by a * (Lesion group, PRE-vs.
post-surgery), + (Lesion + PNIPAAM
group, PRE-vs. post-surgery), δ (SHAM
group vs. Lesion and
Lesion + PNIPAAM groups) and Ω
(Lesion group vs. Lesion + PNIPAAM
group). (1 symbol, p < 0.05; 2 sym-
bols, p < 0.01 and 3 symbols,
p < 0.001).
Fig. 8. H-reflex recordings. H-reflex rate
sensitivity, measured after increasing
the frequency of stimulation, shows si-
milar profiles in the SHAM and the
Lesion + PNIPAAM groups. Significant
difference between the Hmax/Mmax
ratio is indicated by a *. For a given
frequency, significant difference be-
tween the SHAM and the lesion groups
is indicated by a δ. Significant differ-
ence between the Lesion + PNIPAAM
and the Lesion groups is indicated by a
Ω. Significant difference between the
SHAM and the Lesion + PNIPAAM
groups is indicated by a #. (1 symbol,
p < 0.05; 2 symbols, p < 0.01 and 3
symbols, p < 0.001).
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marrow stromal cell attachment and viability in vitro. More recently, it
has been shown that striatal progenitors from human pluripotent stem
cells (hPSCs) developed a medium spiny neurons-like phenotype when
transplanted into a transgenic mouse model of Huntington disease
[106,107]. The same group previous reported that midbrain dopami-
nergic neurons may differentiate from hPSCs when cultured in PNI-
PAAM-g-PEG hydrogel and transplanted into rat striatum [108,109].
4.3. PNIPAAm-g-PEG does not increase endogenous inflammation
The second step of our demonstration was to verify that our
PNIPAAm-g-PEG hydrogel did not trigger an additional inflammation
[110–113]. Implantation of the hydrogel had no negative influence on
inflammation, suggesting that it could be a good candidate for spinal
cord repair. Previous reports on that topic are conflicting. One study
demonstrated that PNIPAAm-g-PEG hydrogel elicited a considerable
inflammatory response when injected in the striatum [105]. Con-
versely, evaluating reactive macrophages and microglia levels (IBA-1
labeling), Conova et al. [78] reported that PNIPAAm-g-PEG hydrogel
did not elicit a greater host inflammatory response than the commer-
cially available Gelfoam® or Vitrogen PureCol® matrix known to be a
biocompatible scaffold material.
Tunesi et al. [105] used ratios of PNIPAAm/PEG of 100/1.2mg/ml,
200/1.2mg/ml and 300/1.2mg/ml (with NIPAAm: 10000 g/mol and
PEG: 3350 g/mol), the hydrogel being here made of separated PNI-
PAAm and PEG homopolymer, namely PEG contents ranging from 0.4
to 1.2 wt% while Conova et al. [78], used a molar ratio of NIPAAm/PEG
of 1000/1 (with PEG: 8000 g/mol) which corresponds to PEG content of
6.6 wt%, close to that of our hydrogel (6 wt%). Thus, it cannot be ex-
cluded that PEG in the hydrogel is beneficial to decrease the in-
flammation. Furthermore, in contrast to the hydrogel of Conova et al.
(chemically cross-linked) [78], our hydrogel was physically cross-
linked, which may further contributed to a reduced inflammation.
4.4. PNIPAAm-g-PEG improves sensory and motor recovery
As soon as the first week post-injury, the decline in sensori-motor
score of the hemisected rats (Lesion and Lesion + PNIPAAM groups)
was in accordance with previous studies showing the important deficit
after identical spinal cord lesion [26,82,114]. Although some sponta-
neous improvements were noticed with BBB score, all behavioral (BBB-
derived test, ladder climbing test, grip strength test, tape removal test)
tests used in our study showed greater recovery in animal groups with
an hydrogel immediately implanted after the spinal cervical (C2) cord
hemisection. All scores were improved fromW2/W3, except for the grip
strength task mainly involving the motor pathways that showed
improvement from W5. These results indicate that the matrix was
beneficial when injected immediately after the spinal lesion suggesting
that the hydrogel may 1) limit the extension of the lesion (secondary
injury) and/or 2) restrain the formation of the glial scar preventing the
axon regeneration and/or 3) promote the axon regrowth or sprouting
from injury or spare axons. However, if comparison can be made be-
tween studies, results of our study (C2 hemisection, BBB-derived test)
are not in accordance with results of a recent study showing no dif-
ference in BBB scores (BBB test) between animals with a moderated
contusion injury at T9/T10 and animals with the same lesion receiving
one-week post SCI a PNIPAAm-g-PEG hydrogel (PEG: 8000 g/mol,
molar ratio NIPAAm/PEG: 1000/1) loaded with BDNF/NT3 [115]. In
this model of thoracic lesion, the authors did not evaluate the efficacy
of the hydrogel alone. Previously, it was shown that the same PNI-
PAAm-g-PEG hydrogel loaded with BDNF induced greater motor
(single-pellet reach-to-grasp task, staircase-reaching task and cylinder
task) recovery than PNIPAAm-g-PEG alone in a model of cervical (C3/
C4) unilateral dorsolateral funiculotomy ablating the rubrospinal tract
but sparing the dorsal and ventral corticospinal tract [79]. In this model
of cervical lesion, the authors did not compare the efficacy of the hy-
drogel to the spinal lesion alone.
Previous studies, using natural or synthetic hydrogels such as chit-
osan, pHPMA, PLA-b-PHEMA, reported behavioral improvements when
transplanted in the C2 hemilesioned cavity suggesting the potential
benefits of tissue engineering material [25,26,82]. In our experiment,
we used a material liquid at ambient temperature and gelling at body
temperature, i.e., once the temperature is raised it solidifies into a soft
hydrogel allowing to be injected through small gauge needles
[116,117]. Thus, our hydrogel presents the advantage to be injected
into the lesion cavities and to fill all the tortuosities of these cavities
better than implantable and semi-rigid hydrogels as previously de-
scribed [78]. Contrary to few PNIPAAm-g-PEG based hydrogels devel-
oped for spinal cord repair, which were chemically cross-linked (use of
dimethacrylate as a crosslinker), our designed hydrogel relied on phy-
sical non-covalent crosslinking, offering potentially improved de-
gradation/renal excretion features [75]. Thus, our hydrogel was not
strictly degradable and, as non-degradable polymers, hydrogel calcifi-
cation and prolonged inflammatory response might limit long-term
axonal regeneration [4,118]. In addition, axonal regeneration is re-
stricted to the existing pores of the hydrogel that may limit the number
of regenerating processes.
Thus, even if our hydrogel has a great potential for the repair of the
spinal cord, it will have to be improved to make it degradable and
absorbable.
Fig. 9. Histological assessment of neurite outgrowth in the hydrogel after SCI. In the damaged spinal tissues, the cysts (delineated by the white dot line) were surrounded
by the glial scar highlighted by an enhanced GFAP-Ir (red). The hydrogel (H) filled up all the cavities in the lesion site. While only a few glial processes (white arrows)
colonized the hydrogel, up to 15 μm inside (A), NF-immunoreactive neurites (green) invaded the loaded gel (B). Interestingly, the rostro-caudal orientation of the
fibers in the spared tissue was also observed in the hydrogel. By contrast, the NF-Ir in the glial scar was restricted to rare thin neurites (C). R: Rostral, C: Caudal, M:
Medial, L: Lateral. Scale Bar: 50 μm. (For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.)
M. Bonnet, et al. Materials Science & Engineering C 107 (2020) 110354
11
4.5. PNIPAAm-g-PEG restores the post-activation depression of the H-reflex
In mammal, SCI is followed by a ‘spinal shock’ period characterized
by a muscle paralysis, a hypotonia and a loss of reflexes below the level
of injury. Several weeks after injury, these initial troubles are replaced
by a spastic syndrome characterized by exaggerated tendon jerk, hy-
pertonia and muscle spam [119]. The spinal lesion induces 1) an in-
crease in the amplitude of the H-reflex and in the Hmax/Mmax ratio at
the baseline stimulation and 2) a decrease in the post-activation de-
pression upon low-frequency stimulation.
At 12 weeks post-injury, calculation of the Hmax/Mmax ratio at the
baseline stimulation indicated that the value of the Lesion + PNIPAAM
group was similar to that of the SHAM group, the value of the Lesion
group remaining higher than the two other groups. Furthermore, eva-
luation of the rate sensitivity of the H-reflex (i.e., the decrease in reflex
magnitude relative to repetition rate) indicated that animals receiving
the PNIPAAm-PEG hydrogel presented, as the SHAM group, a depres-
sion when the frequency of stimulation increased. On the contrary, in
the Lesion group, the Hmax/Mmax ratios normalized to data obtained at
0.3 Hz did not significantly decrease and remained higher than the two
other groups at 5 and 10 Hz suggesting a hyper-reflexia following SCI.
Our results may suggest that the hydrogel injected into the lesion
cavity may induce a beneficial reorganization of the sensori-motor loop
by changing the level of sublesional motoneuron excitability. Indeed,
we can hypothesize that recovery of the sensori-motor loop (and con-
sequently of the Hmax/Mmax ratio) is the result of the return of the
cortical and subcortical influx to networks connecting muscles from
regenerating axons thought the lesion site and/or Ia afferent pre-
synaptic inhibition and/or Ia afferent reciprocal inhibition of antagonist
muscle and/or plasticity of spared descending pathways with the for-
mation of new synapse with motoneurons or by changing the level of
neurotransmitter released [120–124].
Recently, Tom et al. [115] reported a loss of frequency-dependant
depression property in animals receiving PNIPAAm-g-PEG combined
with BDNF/NT3 and no difference with SCI group. They only observed
a restoration in groups in which treadmill training was added to the
treatment but they did not evaluate the efficacy of the hydrogel alone.
Furthermore, compared to our study, the authors used a model of
moderate T9/T10 contusion injury and performed the hydrogel injec-
tion one week post-injury which could also explain the difference with
our results.
In the context of spinal cord injury, biomaterial matrixes are gen-
erally used to bridge the gap created by spinal cord damage and to
replace the lost tissue in order to provide support for regrowth of da-
maged axons. Previously, it was shown a recovery in the post-activation
depression of the H-reflex after a T10 or a C2 spinal hemisection and
implantation of a pHPMA or a chitosan hydrogel, respectively [25,82].
The authors concluded that the graft of a non-toxic material within the
lesion cavity may bring a suitable environment for i) regenerating da-
maged neurons, ii) preventing the secondary damage and iii) limiting
the glial scar development allowing thus a higher neuroplasticity.
Finally, no physiological reflex recovery was observed in the group
of animals receiving the hydrogel when a repetitive stimulation was
applied to the Tibialis anterior muscle in order to activate the metabo-
sensitive (thinly myelinated and unmyelinated fibers from groups III
and IV) afferent fibers. This result indicates that the hydrogel failed to
restore the ascending pathways involved in ventilatory adjustments.
Previously, it was showed, using pHPMA and chitosan hydrogels im-
planted at the T10 and C2 levels, respectively, a recovery of the
adaptive ventilatory response to muscle fatigue [25,82]. The authors
concluded that the implanted hydrogel allows the transmission of the
sensory influxes from the muscle to the supra-spinal cord after activa-
tion of metabosensitive afferents that inform throughout the spinal
pathway, the brainstem center of the muscle contraction rate. Since this
recovery may have an anatomical basis, with the reorganization of
segmental, intersegmental and suprasegmental nervous nertworks
allowing messages to be traced back to the nervous treatment centers,
our results suggest that plasticity mechanisms were not fully at play, 12
weeks post-hydrogel injection.
4.6. PNIPAAm-g-PEG supports axonal regeneration
Our results indicate that axons grew into the hydrogel and, similarly
to the spared tissue, they were oriented along the rostro-caudal axis. In
addition, only few glial processes colonized the hydrogel while a lim-
ited number of neurites penetrated in the glial scar. These very inter-
esting results point out the high potential of the hydrogel to support
axonal regeneration and may explain the functional recovery we ob-
served in animals receiving copolymer, immediately after the C2
hemisection. Previously, it was reported that PNIPAAm-g-PEG hydrogel
supported axonal regrowth when BDNF was combined to the hydrogel
[78,79]. Our results are in line with these previous results and highlight
the potential of the PNIPAAm-g-PEG copolymer for repairing the spinal
cord.
4.7. The use of biomaterials in a high cervical hemisection model
The cervical hemisection interrupts descending pathways as well as
propriospinal pathways to thoracic and lombosacral segments. Most of
the supraspinal descending influx are conveyed to motoneurons in the
ventral horn via different groups of interneurons within the inter-
mediate grey and dorsal horn. Thus, cervical hemisection induces
motor and sensory deficits in the hindlimb as well as in the forelimb and
complete high cervical hemisection a functional quiescence of the ip-
silateral hemidiaphragm.
Although the rat cervical hemisection model has been widely used
to study different spinal cord repair strategies, few studies using bio-
materials have used this model.
Thus, it was previously demonstrated, after a partial cervical
hemisection completely ablating the lateral funiculus and implantation
of a pHEMA or a pHEMA soaked in 1 μg of BDNF, a modest cellular
inflammatory responses that disappeared by 4 weeks and minimal
scarring around the hydrogel and a considerable angiogenesis pro-
moting axonal penetration into the biomaterial [125]. In others studies
in which the dorsolateral funiculus was injured at the C4 level, it was
showed that, in absence of immune suppression, grafting of alginated
encapsulated BDNF-producing fibroblast survived and induced by 5
weeks a partial recovery of forelimb usage in a test of vertical ex-
ploration and of hindlimb function while crossing a horizontal rope
[126,127]. Immunocytochemical examination revealed RT-97, 5-HT,
CGRP and GAP-43 containing axons surrounding the transplant within
the lesion, indicating axonal regeneration. Furthermore, Liu et al. [128]
reported, after a complete C5 lateral spinal cord hemisection, that im-
plantation of Schwann cell-seeded alginate hydrogels combined to a
caudal rAAV5-GFP/BDNF injection induced by 8 weeks a regeneration
of serotoninergic (propriospinal) and descending (supraspinal) axons
throughout the scaffold.
Finally, only the study of Nawrotek et al. [82] can be compared to
our study. The authors studied the efficacy of a chitosan hydrogel im-
planted in a cervical lesion by following sensorimotor recoveries for 12
weeks and then using electrophysioogical recordings. They showed,
after implantation of a chitosant hydrogel into a C2 hemisection, an
improvement in the ladder climbing and grip strength test scores, in
ventilatory adaptation to muscle fatigue and temporary asphyxia, and a
return in the H-reflex rate sensitivity. The authors concluded that hy-
drogel based on chitosan constitute a promising therapeutic approach
to repair damaged spinal cord. However, although chitosan is con-
sidered as a promising biocompatible biomaterial for spinal cord repair,
it presents some drawbacks. Indeed, as natural biomaterials, it may
contain impurities, presents poor solubility at physiological pH and a
variability in its physico-chemical properties making it a biomaterial
that is difficult to functionalize.
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5. Conclusion
In the current study, we showed that the PNIPAAm-g-PEG hydrogel
copolymer exhibits mandatory properties to be used as a CNS scaffold.
Indeed, this hydrogel is a non toxic matrix that 1) supports survival and
proliferation of hOE-MSCs in vitro, 2) does not increase endogenous
inflammation, 3) is permissive for axonal regowth and 4) improves
sensori-motor recovery. These improvements may be the result of a
more suitable environment allowing axonal regeneration and survival
of damaged neurons as well as limitation of the glial scar development
and secondary damages and/or a higher neuroplasticity expression.
Due to its high therapeutic potential, this hydrogel is a potent
candidate that can be used as an adjuvant with other strategies (re-
habilitation, anti-inflammatory molecules, neurotrophic factors, stem
cells …) or associated to an intravenous injectable strategy [129] to
repair the spinal cord. The next step will be to optimize the copolymer
by combining it with bioactive molecules and cells, in order to enhance
functional outcome after SCI.
This study is part of a larger study whose goal is, ultimately, to lead
to a clinical trial.
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